Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics of participants

From: Effects of N-acetylcysteine on the expressions of UCP1 and factors related to thyroid function in visceral adipose tissue of obese adults: a randomized, double-blind clinical trial

Variables

Groups, mean (SD)

P-valuea

NAC (n = 22)

Control (n = 21)

Age, y

41.09(5.25)

40.18(6.32)

0.598

Female (n, %)

12 (54.5)

11 (52.3)

0.609

Weight (kg)

125.02(12.12)

126.88(11.60)

0.810

BMI (kg/m2)

44.36(3.04)

44.03(4.09)

0.609

Waist-circumference (cm)

137.55(11.07)

136.27 (10.39)

0.936

FT3 (pmol/L)

4.47 (0.59)

4.51(0.57)

0.825

FT4 (pmol/L)

14.82(1.29)

14.87 (1.12)

0.894

TSH (mIU/L)

2.23(0.49)

2.35(0.66)

0.547

Physical Activity (met.h/wk)

1221.00(651.03)

1199.91(741.21)

0.981

Multivitamin use (n, %)

6(27.2)

6(28.5)

0.990

Drug use (n, %)

9 (40.9)

10 (47.6)

0.498

  1. a Data obtained from independent sample T-Test for continuous variables and Chi-square for categorical variables
  2. Abbreviations: NAC: N-Acetylcysteine, BMI: Body mass index, FBS: Fasting blood sugar, HDL-C: High density lipoprotein-cholesterol, HOMA_IR: Homeostatic model assessment-insulin resistance, LDL-C: Low density lipoprotein-cholesterol; TC: Total cholesterol, TG: Triglycerides, WC: Waist circumference, hs-CRP: high-sensitivity C-reactive protein